HDAC inhibitor developed at Enzo Life Sciences. Inhibits HDAC activity in HeLa nuclear extracts (IC50=5-10µM).
Product Details
Formula: | C20H25N3O2 |
|
MW: | 339.4 |
|
CAS: | 537034-17-6 |
|
Purity: | ≥98% (TLC) |
|
Appearance: | Tan solid. |
|
Solubility: | Soluble in DMSO (25mg/ml) or 100% ethanol (10mg/ml, warm) |
|
Shipping: | Ambient Temperature |
|
Long Term Storage: | -20°C |
|
Regulatory Status: | RUO - Research Use Only |
|
Please mouse over
Product Literature References
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia: D. Herman, et al.; Nature Chem. Biol.
10, 551 (2006),
Abstract;
The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines: J. Savickiene et al.; Eur J Pharmacol
549, 9 (2006),
Abstract;